Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Leukemia|December 21, 2007
Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcomeU Norén-Nyström, G Roos, A Bergh, et al.
Leukemia|March 1, 1996
Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID miceA K Palucka, R Scuderi, A Porwit, et al.
Leukemia|May 23, 2001
Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALLM Malec, E Björklund, S Söderhäll, et al.
Leukemia|April 1, 1997
Expression of LAZ3/BCL6 in follicular center (FC) B cells of reactive lymph nodes and FC-derived non-Hodgkin lymphomasS Bajalica-Lagercrantz, F Piehl, J Lagercrantz, et al.
British Journal of Cancer|September 24, 2009
Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphomaA Birgersdotter, K R N Baumforth, A Porwit, et al.
Virchows Archiv : an International Journal of Pathology|July 12, 2022
EAHP 2020 workshop proceedings, pediatric myeloid neoplasmsR J Leguit, A Orazi, N Kucine, et al.
Journal of Internal Medicine|April 4, 2012
T-cell phenotypes in bronchoalveolar lavage fluid, blood and lymph nodes in pulmonary sarcoidosis--indication for an airborne antigen as the triggering factor in sarcoidosisP Darlington, H Haugom-Olsen, K von Sivers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 21, 2010
Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartomaA Chiu, M Czader, L Cheng, et al.
Leukemia & Lymphoma|February 26, 1999
Intraclonal heterogeneity in the in vitro daunorubicin-induced apoptosis in acute myeloid leukemiaK A Palucka, E Knaust, D Xu, et al.
Leukemia|January 30, 2004
Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemiaJ Lundin, A Porwit-MacDonald, E D Rossmann, et al.
Pageof 12